FDA inspection
Yabao Pharmaceutical Co., Ltd. Beijing: FDA inspection ending Nov 8, 2019
FDA inspection 1112102 · No Action Indicated (NAI) · Beijing
Key facts
| Inspection ID | 1112102 |
|---|---|
| Firm | Yabao Pharmaceutical Co., Ltd. Beijing |
| FEI number | 3009071264 |
| Address | 97 Kechuang East 6th Street, BDA |
| City | Beijing |
| Fiscal year | 2020 |
| Inspection end date | Nov 8, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data